Practical and clinical utility of non-invasive vagus nerve stimulation (nVNS) for the acute treatment of migraine: a post hoc analysis of the randomized, sham-controlled, double-blind PRESTO trial

Overview of attention for article published in The Journal of Headache and Pain, October 2018

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (90th percentile)
Good Attention Score compared to outputs of the same age and source (78th percentile)

Mentioned by

news: 3 news outlets

twitter: 5 X users

Citations

dimensions_citation: 18 Dimensions

Readers on

mendeley: 86 Mendeley

Summary News X Dimensions citations

So far, Altmetric has seen 3 news stories from 3 outlets.

New—and surprising—ways to approach migraine pain

Pediatric News , 13 Jun 2022

J Fam Pract. 2022 June;71(5):198,218 | doi: 10.12788/jfp.0432 Migraine headaches pose a challenge for many patients and their…

Vagus Nerve Stimulation on Par With Triptan in Episodic Migraine

Medical Health News, 12 Jul 2019

CONFERENCE REPORTER Noninvasive transdermal vagus nerve stimulation (nVNS) appears to be as effective as triptan therapy for…

Vagus Nerve Stimulation Quickly and Consistently Reduces Pain Intensity, Rescue Medication Use in Migraine

AJMC, 08 Nov 2018

Data from a post hoc analysis is adding to positive literature on vagus nerve stimulation, concluding that the treatment…

This page shows the most recent news stories that mention this research output.

Click here to find out how to access more activity.